What Clinect does

Clinect is an Australian-based pharmaceutical company that supplies branded medicines and medical devices to hospital and pharmacy channels across Australia and New Zealand, operating as a wholly-owned subsidiary of EBOS Group Ltd. The company's product portfolio spans multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology, with branded products such as Famvir (famciclovir), Naprosyn (naproxen), Haldol Decanoate (haloperidol), Valium (diazepam), Reagila (cariprazine), Largactil (chlorpromazine), and Kytril (granisetron). Clinect also distributes medical devices including the Neria Steel and Neria Soft subcutaneous infusion systems. Headquartered in Melbourne Docklands, the company focuses on clinically essential and niche products that require special regulatory attention and knowledge.

Beyond product distribution, Clinect provides a full suite of market-access services to international pharmaceutical companies seeking entry into the Australian and New Zealand markets. These services include regulatory affairs (TGA and Medsafe submissions covering PI, CMI, and labelling), reimbursement strategy and submissions (PBAC and PHARMAC), medical affairs including pharmacovigilance and drug information, validated cold-chain warehousing and distribution, key opinion leader engagement with Directors of Pharmacy in public hospitals and private healthcare organizations, and tailored sales and marketing solutions. The business model combines product acquisition and strategic partnering to bring niche treatments to market, with revenue generated through pharmaceutical product sales under PBS and PHARMAC regulated pricing. The company employs a sales-led go-to-market motion with direct enterprise sales targeting hospitals and pharmacies through established KOL relationships, with only two senior leaders publicly identified (Merryn Wallace, General Manager; Marcos Bernardo, Commercial Manager), indicating a lean operational structure consistent with a focused specialty distributor.

Name

Clinect

Legal name

Clinect

Website

https://clinect.com.au

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

Clinect is an Australian pharmaceutical subsidiary of EBOS Group that supplies branded niche medicines, clinically essential treatments, and medical devices to hospitals and pharmacies across Australia and New Zealand, with full-service market access capabilities covering regulatory, reimbursement, distribution, and KOL engagement.

Ownership category

akta.pro rank

Headquarters

HQ city

Melbourne (Docklands)

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from supplying pharmaceutical products and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of branded medicines and medical devices in Australia and New Zealand markets through strategic partnering and product acquisition. The company focuses on clinically essential and niche pharmaceutical products distributed to public hospitals, private healthcare organisations, and community and hospital pharmacies, with supporting services including regulatory affairs (TGA/Medsafe), reimbursement support (PBAC/PHARMAC), validated cold chain warehousing and distribution, medical affairs (pharmacovigilance, drug information), market entry strategy, and tailored sales and marketing.

Product overview

Clinect is an Australian-based pharmaceutical company that supplies a portfolio of medicines and medical devices in Australia and New Zealand. The company operates as a pharmaceutical products and services business, offering a comprehensive portfolio of branded medications across multiple therapeutic areas including cardiovascular, central nervous system, anti-inflammatory, antiviral, and oncology treatments. Products include Anaprox®, Bondronat®, Catapres®, Crysanal®, Famvir®, Haldol® Decanoate, Kytril®, Largactil®, Naprosyn®, Reagila®, Reminyl®, Tenormin®, Toradol®, Valium®, and ZYAMIS® among many others. In addition to pharmaceutical products, Clinect provides supporting services including market entry strategy, medical affairs, warehousing and distribution with cold chain capabilities, regulatory affairs (TGA and Medsafe submissions), key opinion leader relationships, reimbursement support (PBAC and PHARMAC), and sales and marketing services. The company focuses on specialty and niche pharmaceutical products that require special attention and regulatory expertise, distributing through hospital and pharmacy channels via strategic partnering and product acquisition.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Entry Services
• Medical Affairs Services
• Warehousing & Distribution Services
• Regulatory Affairs Services
• Key Opinion Leader Relationship Services
• Reimbursement Services
• Sales & Marketing Services
• Neria Steel
• Neria Soft
• Anaprox Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging for hospital and pharmacy channels in Australia and New Zealand.
• Bondronat Bisphosphonate medication containing Ibandronate Sodium 50mg, supplied as 28 tablets in blister packaging for the treatment of bone conditions.
• Catapres Antihypertensive medication containing Clonidine Hydrochloride, available in injectable (150mcg/mL, 5 ampoules) and tablet (100mcg, 150mcg, 100 tablets) formulations.
• Crysanal Anti-inflammatory pain relief medication containing Naproxen Sodium 550mg, supplied as 50 tablets in blister packaging.
• Diltiazem CD Calcium channel blocker containing Diltiazem Hydrochloride 120mg, supplied as 500 capsules in bottle packaging.
• Doxazosin Alpha-blocker medication containing Doxazosin mesilate available in 2mg and 4mg tablet formulations, supplied as 500 tablets in bottles.
• Elovax Antiviral medication containing Famciclovir 500mg for viral infections, supplied as 3 tablets in blister packaging.
• Famvir Antiviral medication containing Famciclovir available in multiple strengths (125mg, 250mg, 500mg) and pack sizes (20-56 tablets) for herpes and shingles treatment.
• Felodur ER Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.
• Frisium Benzodiazepine medication containing Clobazam 10mg, supplied as 50 tablets in blister packaging for anxiety and seizure disorders.
• Haldol Decanoate Antipsychotic long-acting injection containing Haloperidol available in 50mg/1mL, 100mg/1mL, and 150mg/3mL formulations, supplied as 5 ampoules.
• Imdur Antianginal medication containing Isosorbide Mononitrate available in 60mg and 120mg strengths, supplied as 30 tablets in blister packaging.
• Inderal Beta-blocker medication containing Propranolol available in 10mg and 40mg strengths, supplied as 100 tablets in blister packaging.
• Iopidine Ophthalmic solution containing Apraclonidine 5mg/mL, supplied as 5mL bottle for glaucoma treatment.
• Kytril Antiemetic medication containing Granisetron available in injectable (1mg/1mL, 3mg/3mL) and tablet (2mg) formulations for chemotherapy-induced nausea.
• Largactil Antipsychotic medication containing Chlorpromazine Hydrochloride available in injectable (50mg/2mL), oral suspension (25mg/5mL), and tablet (25mg, 100mg) formulations.
• Leustatin Antimetabolite chemotherapy agent containing Cladribine 1mg/1mL, supplied as 1 vial for hairy cell leukemia treatment.
• Maraviroc Waymade Antiretroviral medication containing Maraviroc available in 150mg and 300mg strengths, supplied as 60 tablets in blister packaging.
• Metaraminol Torbay Vasopressor medication containing Metaraminol available in 5mg/10mL and 10mg/1mL injectable formulations, supplied as 10 ampoules.
• Monodur Antianginal medication containing Isosorbide Mononitrate 120mg, supplied as 30 tablets in blister packaging.
• Naprosyn SR Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.
• Naprosyn Anti-inflammatory pain relief medication containing Naproxen 250mg, supplied as 50 tablets in blister packaging.
• Nozinan Antipsychotic medication containing Levomepromazine Hydrochloride available in 25mg and 100mg tablet formulations, supplied as 100 tablets in blister packaging.
• Neulactil Antipsychotic medication containing Periciazine available in 2.5mg and 10mg strengths, supplied as 100 tablets in blister packaging.
• Neupedix Prostaglandin medication containing Alprostadil 500mcg/1mL, supplied as 5 ampoules for erectile dysfunction treatment.
• Persantin Antiplatelet medication containing Dipyridamole 10mg/2mL, supplied as 5 ampoules for cardiovascular protection.
• Plendil ER Extended-release calcium channel blocker containing Felodipine available in 2.5mg, 5mg, and 10mg strengths, supplied as 30 tablets in blister packaging.
• Pravastatin Statin medication containing Pravastatin Sodium available in 20mg and 40mg strengths, supplied as 100 tablets in bottle packaging.
• Prednisone Corticosteroid medication available in 1mg, 2.5mg, 5mg, and 20mg tablet formulations, supplied as 500 tablets in bottle packaging.
• Priadel Mood stabilizer containing Lithium Carbonate 400mg, supplied as 100 tablets in blister packaging for bipolar disorder treatment.
• Primidone Anticonvulsant medication containing Primidone 250mg, supplied as 100 tablets in bottle packaging.
• Proveblue Diagnostic agent containing Methylene Blue 50mg/10mL, supplied as 5 ampoules for methemoglobinemia treatment.
• Proxen SR Extended-release anti-inflammatory medication containing Naproxen available in 1g and 750mg strengths, supplied as 28 tablets in blister packaging.
• Reagila Atypical antipsychotic containing Cariprazine available in 1.5mg, 3mg, 4.5mg, and 6mg capsule strengths, supplied as 30 capsules in blister packaging.
• Reminyl Cholinesterase inhibitor containing Galantamine available in 8mg, 16mg, and 24mg capsule strengths, supplied as 28 capsules in blister packaging.
• Rocaltrol Vitamin D analog containing Calcitriol 0.25mcg, supplied as 100 capsules in blister packaging.
• Stemetil Antiemetic medication containing Prochlorperazine mesilate 12.5mg/1mL, supplied as 10 ampoules.
• Synacthen Adrenocorticotropic hormone (ACTH) containing Tetracosactide 0.25mg, supplied as 1 ampoule for adrenal function testing.
• Syntometrine Uterotonic medication containing Oxytocin/Ergometrine maleate 5 IU/mL/0.5mg/mL, supplied as 5 ampoules for postpartum hemorrhage.
• Tenormin Beta-blocker medication containing Atenolol 50mg, supplied as 30 tablets in blister packaging.
• Testavan Testosterone replacement therapy gel containing Testosterone 20mg/1g, supplied as 56 doses/85.5g pump dispenser.
• Toradol NSAID pain medication containing Ketorolac Trometamol available in injectable (10mg/mL, 30mg/1mL) and tablet (10mg) formulations.
• Tranexamic Acid Waymade Antifibrinolytic medication containing Tranexamic Acid 500mg, supplied as 100 tablets in blister packaging.
• Trental Vasodilator medication containing Pentoxifylline 400mg, supplied as 50 tablets in blister packaging.
• Trientine Waymade Chelating agent containing Trientine dihydrochloride 250mg, supplied as 100 capsules in bottle packaging for Wilson's disease.
• Valium Benzodiazepine medication containing Diazepam 5mg, supplied as 50 tablets in blister packaging.
• Verdye Diagnostic imaging agent containing Indocyanine Green 25mg, supplied as 5 vials for liver function and ophthalmic imaging.
• Xadago MAO-B inhibitor containing Safinamide available in 50mg and 100mg tablet strengths, supplied as 30 tablets in blister packaging for Parkinson's disease.
• Xorox Topical antiviral cream containing Aciclovir 30mg/g, supplied as 4.5g tube for herpes treatment.
• Zarontin Anticonvulsant medication containing Ethosuximide available in 250mg capsules and 250mg/5mL oral solution, supplied in bottles.
• Zestril ACE inhibitor containing Lisinopril available in 5mg, 10mg, and 20mg tablet strengths, supplied as 30 tablets in blister packaging.
• ZYAMIS Benzodiazepine pre-filled syringe containing Midazolam available in 2.5mg/0.25mL, 5mg/0.5mL, 7.5mg/0.75mL, and 10mg/1mL formulations for sedation.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• iNova Pharmaceuticals: Specialty pharmaceutical company focused on prescription and OTC medicines across ANZ and Asia-Pacific. Comparable to Clinect in therapeutic-area breadth, channel coverage, and partnership-based product sourcing.
• Sigma Healthcare: One of Australia's largest pharmaceutical wholesalers and distributors, serving community pharmacies with a broad portfolio including specialty products. Directly comparable as an ANZ pharma distributor with hospital and pharmacy channel coverage.
• Arrotex Pharmaceuticals: Australia's largest generic pharmaceutical company with branded specialty, OTC, and hospital portfolios. Competes with Clinect in hospital and pharmacy channels across overlapping therapeutic areas.
• Specialised Therapeutics Australia: Australian specialty pharma company that partners with international firms to bring niche and oncology products to the ANZ market. Closest comparable to Clinect's "niche/specialty" in-licensing and distribution model.
• Australian Pharmaceutical Industries (API): Major Australian pharmaceutical distributor and pharmacy services group (now part of Wesfarmers). Operates the same hospital and community pharmacy distribution channels that Clinect serves, with overlapping product portfolios.

Broad incumbents

• Servier Australia: Australian subsidiary of global specialty pharma group Servier. Operates in overlapping therapeutic areas (cardiovascular, oncology, CNS) and follows a similar in-licensing / partnered commercialisation model in ANZ.
• Aspen Pharmacare Australia: Australian subsidiary of Aspen Pharmacare, distributing branded specialty and generic pharmaceuticals. Comparable channel footprint and product categories to Clinect, with broader international scale.
• Apotex Australia & New Zealand: Subsidiary of global generic manufacturer Apotex, with significant ANZ presence in prescription and specialty generics. Competes with Clinect's portfolio of mature molecules across hospital and pharmacy channels.

Emerging players

• Seqirus: CSL subsidiary focused on specialty vaccines and biologics in ANZ and globally. Comparable to Clinect in cold chain capability, specialty product focus, and ANZ hospital channel.
• Link Healthcare: ANZ specialty pharma company that in-licenses and distributes niche prescription products to hospitals and specialists. Closely comparable to Clinect's partnership-driven, niche-focus distribution model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/clinect

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinect